In non-JAK2 mutated or non-CRLF2-overexpressing cases, gain of function mutations are found in CRLF2 or IL7RA genes, strongly implicating cytokine signaling as a major transforming process in DS–ALL [66, 70, 71]. The gene discussed is JAK2; the disease is acute lymphoblastic leukemia.